Cargando…
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data A...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450015/ https://www.ncbi.nlm.nih.gov/pubmed/28566274 http://dx.doi.org/10.1136/bmj.j2350 |
_version_ | 1783239869519101952 |
---|---|
author | Man, Kenneth K C Chan, Esther W Ip, Patrick Coghill, David Simonoff, Emily Chan, Phyllis K L Lau, Wallis C Y Schuemie, Martijn J Sturkenboom, Miriam C J M Wong, Ian C K |
author_facet | Man, Kenneth K C Chan, Esther W Ip, Patrick Coghill, David Simonoff, Emily Chan, Phyllis K L Lau, Wallis C Y Schuemie, Martijn J Sturkenboom, Miriam C J M Wong, Ian C K |
author_sort | Man, Kenneth K C |
collection | PubMed |
description | Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data Analysis and Reporting System. Participants 190 618 children born in Hong Kong public hospitals between January 2001 and December 2009 and followed-up to December 2015. Main outcome measure Hazard ratio of maternal antidepressant use during pregnancy and ADHD in children aged 6 to 14 years, with an average follow-up time of 9.3 years (range 7.4-11.0 years). Results Among 190 618 children, 1252 had a mother who used prenatal antidepressants. 5659 children (3.0%) were given a diagnosis of ADHD or received treatment for ADHD. The crude hazard ratio of maternal antidepressant use during pregnancy was 2.26 (P<0.01) compared with non-use. After adjustment for potential confounding factors, including maternal psychiatric disorders and use of other psychiatric drugs, the adjusted hazard ratio was reduced to 1.39 (95% confidence interval 1.07 to 1.82, P=0.01). Likewise, similar results were observed when comparing children of mothers who had used antidepressants before pregnancy with those who were never users (1.76, 1.36 to 2.30, P<0.01). The risk of ADHD in the children of mothers with psychiatric disorders was higher compared with the children of mothers without psychiatric disorders even if the mothers had never used antidepressants (1.84, 1.54 to 2.18, P<0.01). All sensitivity analyses yielded similar results. Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30). Conclusions The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously. |
format | Online Article Text |
id | pubmed-5450015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54500152017-06-08 Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study Man, Kenneth K C Chan, Esther W Ip, Patrick Coghill, David Simonoff, Emily Chan, Phyllis K L Lau, Wallis C Y Schuemie, Martijn J Sturkenboom, Miriam C J M Wong, Ian C K BMJ Research Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data Analysis and Reporting System. Participants 190 618 children born in Hong Kong public hospitals between January 2001 and December 2009 and followed-up to December 2015. Main outcome measure Hazard ratio of maternal antidepressant use during pregnancy and ADHD in children aged 6 to 14 years, with an average follow-up time of 9.3 years (range 7.4-11.0 years). Results Among 190 618 children, 1252 had a mother who used prenatal antidepressants. 5659 children (3.0%) were given a diagnosis of ADHD or received treatment for ADHD. The crude hazard ratio of maternal antidepressant use during pregnancy was 2.26 (P<0.01) compared with non-use. After adjustment for potential confounding factors, including maternal psychiatric disorders and use of other psychiatric drugs, the adjusted hazard ratio was reduced to 1.39 (95% confidence interval 1.07 to 1.82, P=0.01). Likewise, similar results were observed when comparing children of mothers who had used antidepressants before pregnancy with those who were never users (1.76, 1.36 to 2.30, P<0.01). The risk of ADHD in the children of mothers with psychiatric disorders was higher compared with the children of mothers without psychiatric disorders even if the mothers had never used antidepressants (1.84, 1.54 to 2.18, P<0.01). All sensitivity analyses yielded similar results. Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30). Conclusions The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously. BMJ Publishing Group Ltd. 2017-06-01 /pmc/articles/PMC5450015/ /pubmed/28566274 http://dx.doi.org/10.1136/bmj.j2350 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Man, Kenneth K C Chan, Esther W Ip, Patrick Coghill, David Simonoff, Emily Chan, Phyllis K L Lau, Wallis C Y Schuemie, Martijn J Sturkenboom, Miriam C J M Wong, Ian C K Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title_full | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title_fullStr | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title_full_unstemmed | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title_short | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
title_sort | prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450015/ https://www.ncbi.nlm.nih.gov/pubmed/28566274 http://dx.doi.org/10.1136/bmj.j2350 |
work_keys_str_mv | AT mankennethkc prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT chanestherw prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT ippatrick prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT coghilldavid prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT simonoffemily prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT chanphylliskl prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT lauwalliscy prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT schuemiemartijnj prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT sturkenboommiriamcjm prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy AT wongianck prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy |